Leading Drug Delivery Companies and Technologies
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
Impact of Pharmacogenomics on Public Healthcare Policy
The Future of Biosimilars: Key opportunities & emerging therapies  
The Biotechnology Market Outlook
The Top 10 Biotechnology Companies
Emerging Drug Discovery Technologies
The Future of Personalized Medicine
Pharmaceutical and Biotech Growth Strategies: Future drivers and opportunities
Winning Pharmaceutical R&D Strategies
The Pharmacoeconomics Outlook: Turning value-for-money requirements into a competitive advantage
The Therapeutic Proteins Outlook To 2007
Winning Drug Delivery Strategies: Maximising product performance through new technologies
The Outlook For The Biotech Sector In The Post-Genomic Era
Pharmaceutical R&D Outsourcing Strategies: An analysis of market drivers and resistors to 2010
Next Generation Drugs: Acceleration Through Innovation
The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets
Opportunities in R&D 2001
The Drug Delivery Outlook 2001
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
The Pharmacogenomics Outlook
Integrating Genomics: The Next Generation
The Drug Delivery Outlook to 2005



SALES AND MARKETING
Launching Combination Products: Brand extension and franchise development strategies
Winning Product Launch Strategies
Indication Expansion: Opportunities for successful lifecycle management
Winning Pharmaceutical Brand Management
Pharmaceutical Branding Strategies
Pharmaceutical Sales Force Strategies
The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM
Winning Product Launch Strategies
The Pharmaceutical Sales Force Outlook
The DTC Marketing Outlook
The Evolution of DTC marketing across key pharmaceutical markets

GENERICS FOCUS
The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
Future Growth Opportunities in Generics
The Top 10 Generics Companies
Growth Strategies in Generics: Innovative and aggressive strategies and their impact...
Generics Defense Strategies
The Biogenerics Market Outlook
The European Generics Outlook
The Pharmaceutical Parallel Trade Outlook
The Generics Outlook 2001
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
Generic Pharmaceutical Outlook 1998-2008

PORTFOLIO AND LIFECYCLE MANAGEMENT
Patent Protection Strategies: Maximising product Revenues
Lifecycle Management Strategies
Pharmaceutical Project and Portfolio Management
Rx-To-OTC Switching Strategies
Patent Protection Strategies: Maximizing market exclusivity
The Pharmaceutical Portfolio Management Outlook
The OTC Outlook to 2007: Extending revenue streams and product lifecycles after patent expiry
Achieving Market Dominance Through Reformulation: A Strategic Insight
Maximising the Drug Lifecycle
The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle
The Pharmaceutical OTC Market to 2010

REGULATION
Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
Drug Safety in the Post-Vioxx Era
Pharma Market Authorization Strategies
Pharmaceutical Regulatory Affairs Outlook 2002: International strategies for faster drug approval
Regulatory Affairs: Paths to Approval

PHARMACEUTICAL INTELLIGENCE
Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
Emerging Pharmaceutical Markets
The Indian Pharmaceutical Market to 2011
The Women’s Health Market Outlook to 2011
Innovation in Drug Delivery
The Specialty Pharma Market Outlook
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China
Exploiting Pharmaceutical Growth Opportunities in Central and Eastern Europe
The Pharmaceutical Market Outlook to 2015
Pharmaceutical Anti-Counterfeiting Strategies
Beyond the Blockbuster Drug
The Women's Health Outlook to 2008
The Pharmaceutical Market Outlook To 2010: Essential Analysis of Key Drivers of Change
The Blockbuster Drug Outlook To 2007
The Blockbuster Drugs Reference: Product and company analysis
Pharmaceutical Innovation: An analysis of leading companies and strategies
The Pharmaceutical Industry Paradox
Strategic Intelligence: The Top 12 Pharmaceutical Companies
Global Orthopaedic Markets: Bridging the Divide
The Pharmaceutical industry in the 21st Century
Top Ten and Emerging Pharmaceutical markets
The US Healthcare Market into the 21st Century
The Pharmaceutical Distribution Outlook 1998-2008
Global Pharmaceutical: a market, company and disease analysis
Healthcare Informatics: into the 21st Century
The Pharmaceutical Profitability Outlook
Managed Care in Global Healthcare Markets

STRATEGIC ALLIANCES AND M&A
Pharmaceutical Strategic Alliances
Pharmaceutical Licensing Strategies
Pharmaceutical Outsourcing Strategies
Pharmaceutical Strategic Alliances: Benchmarking 21st century deal-making
The Pharmaceutical Licensing Outlook: effective deal-making and profitable partnerships
The Pharmaceutical Mergers and Acquisitions Outlook 2001
Pharmaceutical Mergers & Acquisitions: the third wave
The Pharmaceutical Outsourcing Outlook 1998-2003

NEW THERAPEUTIC AREAS
Innovations in The Management of Diabetes: Next generation treatments and market dynamics
The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
The Gastrointestinal Market Outlook to 2012
Autoimmune Market Outlook to 2012
The Dermatology Market Outlook to 2011
The Future of Monoclonal Antibodies Therapeutics
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011
The Diabetes Market Outlook to 2011
The Gastrointestinal Market Outlook to 2010
The Asthma and COPD Market Outlook

JAPANESE PHARMACEUTICAL MARKET
The Japanese Pharmaceutical Companies Outlook
The Japanese Pharmaceutical Market Outlook 2001



The Cardiovascular Disorders Market Outlook to 2012
Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
Innovations in Cardiovascular Disease Management
The Cardiovascular Market Outlook to 2011
The Asian Cardiovascular Market Outlook to 2010
The Latin American Cardiovascular Market Outlook to 2010
The Eastern European Cardiovascular Market Outlook to 2010
The Cardiovascular Market Outlook to 2010
The Diabetes Market Outlook: Market analysis of future growth and leading players by sector
The Cardiovascular Market Outlook to 2009
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
The Cardiovascular Market Outlook to 2008
The Cardiovascular Outlook to 2007
The Lifestyle Drugs Outlook To 2007: Challenges and opportunities in a high-profile growth market
The Cardiovascular Outlook 2000
The Cardiovascular Outlook 1998-2010
Lifestyle Drugs Outlook to 2005



The CNS Market Outlook to 2012
Innovations in CNS: Novel therapeutics and future R&D strategies
The CNS Market Outlook to 2011
The Pain Market Outlook to 2011
The CNS Market Outlook to 2010
The CNS Market Outlook to 2009
The Outlook for Niche CNS Disorders
Commercial Opportunities from an Aging Population
The CNS Market Outlook to 2008
The CNS Outlook to 2007
The CNS Outlook 2000
Pain Therapeutics: A Strategic Re-evaluation.
Antisense Therapy: Technical Aspects and Commercial Opportunities
The CNS Outlook 1998-2010



Innovations in Diagnostics
The Diagnostics Outlook to 2005



eHealth Solutions for Pharma
Harnessing Patient Power
Consumer-Targeted Internet Investment
Physician-Targeted Internet Promotion
The Outlook for eR&D Strategies
Measuring eBusiness In the Pharmaceutical Sector
The Outlook For Direct-To-Consumer Marketing: Maximizing The Return On Your Investment
Advertising medicines and providing health information on the Internet
The Outlook For Direct-To-Consumer Marketing Vol II: Maximizing online potential
Patient Power Outlook 2001
eHealth Tools and eHealth Management: Opportunities and challenges for pharma companies and MCOs
eHealth Connectivity: Linking Players, Providers and Patients
eHealth Content: An analysis of healthcare Information on the Internet
ePharmacies: Strategic Implications for the Healthcare Industry
Patient Power in the Pharmaceutical Industry



The Global HIV/AIDS Market Outlook to 2012
The Global Anti-Infectives Market Outlook to 2011
The Vaccines Market Outlook: Market analysis of future growth and leading players by sector
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
The Antivirals Outlook to 2007



The Cancer Market Outlook to 2012
Innovative and Targeted Cancer Therapies
The Cancer Market Outlook to 2011
The Eastern European Cancer Market Outlook to 2010
The Asian Cancer Market Outlook to 2010
The Latin American Cancer Market Outlook to 2010
The Cancer Market Outlook to 2010
The Cancer Market Outlook to 2009
Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
The Cancer Market Outlook to 2008
New Cancer Therapeutics: An analysis of current and emerging markets
The Cancer Outlook to 2007
The Cancer Outlook 2000
The Cancer Market Outlook 1998-2010



Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies
Pharmaceutical Pricing and Reimbursement
Pharmaceutical Pricing Strategies 2005
Pharmaceutical Pricing Strategies: Optimizing returns throughout R&D and marketing
Cost Effective Healthcare Solutions; The Strategic Impact of Pharmacoeconomics in Key Markets
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
Pharmaceutical Pricing Strategies



Click here for more information on the Drug Discovery series




Click here for more information on the Pharmaceutical Outsourcing Series